These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2307573)

  • 21. [Dosage of slow-release theophyllines: analysis of plasma levels].
    Escarrabill J; Sabater I; Barragán F; Estopá R
    Med Clin (Barc); 1985 Jun; 85(2):81. PubMed ID: 4021619
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum theophylline levels in adult asthmatics: comparison of oral sustained-release and microcrystalline preparations.
    Jones DT; Sears MR
    N Z Med J; 1980 Sep; 92(667):196-8. PubMed ID: 6933358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Panic attack secondary to the oral administration of a sustained-release preparation of theophylline].
    Marcos Sánchez F; Gómez Tello V; Celdrán Gil J; Durán Pérez-Navarro A
    An Med Interna; 1990 Jan; 7(1):53. PubMed ID: 2103203
    [No Abstract]   [Full Text] [Related]  

  • 24. In vivo evaluation of a theophylline oral controlled-release unit dosage form.
    Gangadharan B; Ritschel WA; Hussain SA
    Arzneimittelforschung; 1987 Nov; 37(11):1256-7. PubMed ID: 3440033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Research and development of oral controlled-release dosage forms].
    Moës AJ
    J Pharm Belg; 1989; 44(1):60-70. PubMed ID: 2656982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single dose study of the bioequivalence of two sustained-release theophylline formulations.
    Contreras J; Pérez N; González R; Ontivero E; López M
    Arzneimittelforschung; 1998 Mar; 48(3):259-62. PubMed ID: 9553683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacokinetics of a new fluid theophylline sustained-release drug form. Microcapsules in a sachet].
    Fuchs WS; Weiss G; von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
    Arzneimittelforschung; 1998 May; 48(5A):612-7. PubMed ID: 9676354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the pharmacokinetics of theophylline in asthmatic patients following multiple oral dosing of a sustained-release theophylline tablet formulation.
    Takagi K; Yamaki K; Satake T; Hasegawa T; Ogura Y; Suzuki R; Mizukami Y
    Arerugi; 1985 Nov; 34(11):1006-14. PubMed ID: 4084062
    [No Abstract]   [Full Text] [Related]  

  • 29. Oral fenoterol versus sustained release theophylline in adult asthmatics.
    Lucena MI; Almagro J; Andrade RJ; Hidalgo Sanchez R; Sanchez de la Cuesta F
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):19-23. PubMed ID: 9021437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anxiety crisis (panic attack) secondary to the administration of theophylline in an oral sustained-release preparation].
    Gea J; de Pablo J; Martí J; Picado C; Pujol A; Agustí-Vidal A
    Rev Clin Esp; 1988 Oct; 183(5):280. PubMed ID: 3212257
    [No Abstract]   [Full Text] [Related]  

  • 31. 'Dose dumping' and sustained-release theophylline.
    Welch JS
    Am Fam Physician; 1995 Oct; 52(5):1278, 1284. PubMed ID: 7572551
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetic characteristics of a new sustained-release theophylline capsule with a longer absorption profile: single and multiple dosing bioavailability studies.
    Saccar CL; Green LD; Helsel CL; Niehls ME; Diconcetto JA; Mansmann HC; McGeady SJ
    Ann Allergy; 1983 Apr; 50(4):245-8. PubMed ID: 6340563
    [No Abstract]   [Full Text] [Related]  

  • 33. [How can we optimize therapy with sustained-release theophyllines?].
    Izquierdo I; Torrent J; Cisteró A; Jané F
    Med Clin (Barc); 1988 Apr; 90(17):715. PubMed ID: 3412040
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children.
    Logvinoff MM; Weinstein DB; Watts MT; Seifert B
    Clin Ther; 1986; 8(2):175-80. PubMed ID: 3698064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Initial experiences with "Oranienburg" slow-release theophylline in asthma therapy of children and adolescents].
    Sollich V; Schuster R; Thal W; Köhler E; Walther H
    Kinderarztl Prax; 1990 Jan; 58(1):45-8. PubMed ID: 2332947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms as assessed by salivary data: Part II.
    Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):196-201. PubMed ID: 3710632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Theophylline-retard preparations: relation between drug liberation in vitro and their behavior in the human body].
    Beerbaum H; Kulpe K; Seidel KH; Zand G; Nussbücker B; Wilke A; Rentsch E; Wiesner B; Iwainsky H
    Pharmazie; 1988 May; 43(5):325-9. PubMed ID: 3174809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetics of theophylline. Repeated single evening administration of Pulmo-Timelets slow-release capsules in comparison with theophylline slow-release tablets].
    Heusinger JH; Breuel HP; Behrendt WA; Wolfstädter HD
    Fortschr Med; 1989 Nov; 107(32):692-6. PubMed ID: 2689314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative bioavailability of a new sustained-release theophylline tablet.
    Takagi K; Watanabe T; Satake T; Hasegawa T; Ogura Y; Imaeda N; Mizukami Y
    Arerugi; 1987 Nov; 36(11):1006-11. PubMed ID: 3442492
    [No Abstract]   [Full Text] [Related]  

  • 40. Non-interference of xibornol on the theophylline blood levels.
    Fraschini F; Scaglione F; Maierna G; Savio G; Gattei G; Falchi M
    Int J Clin Pharmacol Res; 1988; 8(1):43-6. PubMed ID: 3366502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.